Celltrion: “Zympentra Shows Consistent Therapeutic Effect Across All Intestinal Inflammatory Sites”
Celltrion announced that its autoimmune disease therapy Zympentra—the U.S. brand name for the subcutaneous (SC) formulation of Remsima…
Zympentra
1 개의 기사가 있습니다.